Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind ...
GlobalData on MSN21h
Sanofi increases ownership stake partaking in pharma buyback trendSanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback